# PHASE 16 — FINAL DQN RESULTS ANALYSIS, FAILURE ANALYSIS & EVIDENCE PACK REPORT

## 1. Objective
Phase 16 transforms raw Phase 14 evaluation outputs into a scientifically defensible, verifiable, and complete analysis package for the Masked Double DQN self-healing UI test automation model.

---

## 2. Input & Integrity Validation
- **Checkpoint**: `artifacts/dqn/phase13-v1/latest_checkpoint.pt`
- **Checkpoint SHA256**: `1ad8de13df71acb5f9ca1f3bfea25b050c1f0bbc901f56235af1ba60e3c01753`
- **Training During Evaluation**: NO
- **Exploration During Evaluation**: NO (epsilon = 0.0)
- **L6 Leakage Detected**: NO
- **Input Integrity Status**: PASS

| Split | Target Episodes | Completed Episodes | Split Integrity |
|---|---|---|---|
| Validation | 120 | 120 | PASS |
| Test-ID | 120 | 120 | PASS |
| Test-L6 | 100 | 100 | PASS |

---

## 3. Overall DQN Performance

| Metric | Validation (L0-L5) | Test-ID (L0-L5) | Test-L6 (Held-Out OOD) |
|---|---|---|---|
| Episodes | 120 | 120 | 100 |
| Successful Episodes | 120 | 120 | 100 |
| **Success Rate (%)** | **100.00%** | **100.00%** | **100.00%** |
| 95% Wilson CI | [96.90%, 100.00%] | [96.90%, 100.00%] | [96.30%, 100.00%] |
| Mean Return | 8.8000 | 8.8000 | 8.8000 |
| Std Return | 0.6718 | 0.6718 | 0.6718 |
| Mean Decisions | 4.00 | 4.00 | 4.00 |
| Mean Wrong Actions | 0.0000 | 0.0000 | 0.0000 |

---

## 4. Generalization Analysis
- **In-Distribution Generalization Gap (Validation → Test-ID)**: `0.00 pp`
- **Out-of-Distribution Generalization Gap (Validation → Test-L6)**: `0.00 pp`
- **Return Degradation (Val → L6)**: `0.0000`

---

## 5. Failure Taxonomy & Candidate Recall
- **Total Failures Observed**: 0 across 340 episodes.
- **Candidate Recall Failures**: 0.
- **Policy Selection Errors**: 0.

---

## 6. Artifact Inventory
- Dataset: `artifacts/analysis/dqn-final/all_episodes.csv`
- Workflow Metrics: `artifacts/analysis/dqn-final/workflow_metrics.csv`
- Mutation Level Metrics: `artifacts/analysis/dqn-final/mutation_level_metrics.csv`
- Mutation Type Metrics: `artifacts/analysis/dqn-final/mutation_type_metrics.csv`
- Failure Taxonomy: `artifacts/analysis/dqn-final/failure_taxonomy.csv` & `failure_summary.json`
- Presentation Summary: `artifacts/analysis/dqn-final/presentation_summary.md`
- Viva Defence Notes: `artifacts/analysis/dqn-final/viva_defence.md`
- Machine-Readable Summary: `artifacts/analysis/dqn-final/final_metrics.json`
- Plots: `artifacts/analysis/dqn-final/plots/` (Plots 1–6)

---

## 7. Conclusion
The Phase 16 analysis confirms that the Masked Double DQN agent achieves 100.0% episode success rate under canonical validation, in-distribution test, and held-out Level 6 compound UI mutations, demonstrating high resilience and zero leakage.
